Concepedia

Fu‐Gang Zhu

FZ

27

Publications

1.1K

Citations

21

H-Index

1998

Active since

Affiliations

Idera Pharmaceuticals (United States)(Current)

Duke University Hospital

Duke Medical Center

Dalhousie University

Everbright International (China)

Fu‐Gang Zhu is an author at Idera Pharmaceuticals (United States) specializing in immunology, medicine, and inflammation.

Top concepts

Publications per year

1998–2023

27

Publications

27

Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism

Kaede Gomi, Fu‐Gang Zhu, Jean S. Marshall · The Journal of Immunology · 2000 · 98 citations · Full text

A Toll-Like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis

Weiwen Jiang, Fu‐Gang Zhu, Lakshmi Bhagat et al. · Journal of Investigative Dermatology · 2013 · 87 citations · Full text

The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides

Fu‐Gang Zhu, Charles F. Reich, David S. Pisetsky · Immunology · 2001 · 79 citations · Full text

Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8

Tao Lan, Ekambar R. Kandimalla, Dong Soo Yu et al. · Proceedings of the National Academy of Sciences · 2007 · 74 citations · Full text

, , +18

Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy

Daqing Wang, Wayne Jiang, Fu‐Gang Zhu et al. · International Journal of Oncology · 2018 · 64 citations · Full text

, , +21

Rows per page

1–5 of 27